3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
4
Ovarian Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinosarcoma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma, Ovarian
1
Teratoma
1
Stomach Neoplasms
1
Stage IA Uterine Sarcoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Recurrence
1
Platinum-Refractory Fallopian Tube Carcinoma
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Interventions
nirogacestat
8
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Cryosurgery
3
X-Rays
2
Toremifene
2
Phantoms, Imaging
2
Blood Specimen Collection
2
vactosertib
1
trifluridine tipiracil drug combination
1
strattice
1
liposomal doxorubicin
1
entinostat
1
anlotinib
1
Vinblastine
1
Taxes
1
Tamoxifen
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Sorafenib
1
Sirolimus
1
Saline Solution
1
Radiotherapy
1
Radiofrequency Ablation
1
Pregnancy
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoid Tumors
×
Taxes
×
Sarcoma
×
Clear all
NCT03275818
2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Completed
69 enrolled